Kadiri Manajunatha temple distributes food packets through MCC workers

Bengaluru, May 22: Karnataka reported 138 fresh cases of coronavirus on Friday, taking the state tally to 1743.

26 patients have been discharged on Friday and in total, 597 people have been discharged in Karnataka while total number of active cases in the state is 1,100. 41 people have succumbed to the virus, informed the state health department.

Out of the 138 cases, 111 are returnees from Maharashtra.Out of the 138 cases, 47 are from Chikkaballapura alone, 10 cases from Raichur eight cases each from Bidar and Mandya, five cases each from Bengaluru Rural and Bengaluru Urban, and 14 are from Hassan.

From Bengaluru Rural, three patients are returnees from Maharashtra. A fifty-five year old female from Bengaluru Rural, has contracted the virus and has been diagnosed with a history of SARI. She is currently under observation at a designated city hospital.

Five patients have tested positive from Bengaluru Urban. A 42-year-old woman tested positive in Bengaluru Urban and has been diagnosed with a history of Influenza-like Illness (ILI). She is currently under observation at a designated city hospital.

Two men, who have tested positive from Dharwad are returnees from Delhi. Both of them are currently under observation at a designated hospital in Hubli. A seventy-five year old male who has contracted the coronavirus has returned from Jharkhand.

Belthangady, May 15: Carcases of more than 50 monkeys were found at Bandaru gram panchayat in the taluka here on Friday.

The carcasses were found on the Kundalapalke-Padmunja road in Bandar village. Locals had seen the monkeys’ carcasses night of Thursday and informed authorities about it.

Kaniyuru Health Centre’s medical assistant Swatantra Rao and Ujire health Centre’s Medical Officer, Forest Department staff, veterinarians and local Panchayat officials visited the spot.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.